Drug Patents owned by Ocular Therapeutix
1. Drug name - DEXTENZA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9254267 | OCULAR THERAPEUTIX | Composite hydrogel drug delivery systems |
Sep, 2024
(1 year, 11 months from now) | |
| US8563027 | OCULAR THERAPEUTIX | Drug delivery through hydrogel plugs |
Feb, 2030
(7 years from now) | |
| US8409606 | OCULAR THERAPEUTIX | Drug delivery through hydrogel plugs |
May, 2030
(7 years from now) | |
Drugs and Companies using DEXAMETHASONE ingredient
Treatment: Dextenza is approved for the treatment of ocular pain following ophthalmic surgery
Dosage: INSERT;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.4MG | INSERT;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.